Fact CheckerSign in

NCT05632406Recruiting

Breathing & Blood Pressure

Source: ClinicalTrials.gov · Last updated 7 Oct 2026

Brief summary (registry, in English)

The purpose of this study is to determine the effect of obesity on cardiovascular responses during various breathing maneuvers.

Status (registry)
Recruiting
Study type
Observational
Enrollment
80 (estimated)
First submitted
14 Nov 2022
Start date
25 Oct 2023
Primary completion date
30 Jun 2027
Lead sponsor
Florida State University
Diseases
Obesity
NCT number
NCT05632406

What you commit to

  • Study type: Observational
  • Planned participants: 80
  • From 25 Oct 2023 to the primary completion date, 30 Jun 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous bariatric surgery
  • Patients who have undergone recent abdominal surgery and those with abdominal hernia.

Other illness

  • Overt cardiovascular, neurological, renal, liver, and/or metabolic illness (e.g., diabetes mellitus)
  • Current, or history of uncontrolled, Stage 2 hypertension (blood pressure \>140 / 90 mmHg; anti-hypertensive medications are permitted)
  • Diagnosis or signs (e.g., values below the lower limit of normal) of overt airway disease(s)
  • If a patient is suffering from a ruptured eardrum or any other condition of the ear.
  • Patients with worsening heart failure signs and symptoms after a respiratory/inspiratory muscle training (IMT) session
  • If you are suffering from a cold, sinusitis, or respiratory tract infection, we advise that you do not use your POWERbreathe IMT device.

Other

  • Not weight stable (\<5% change in body mass over the past six months)
  • Diagnosed obstructive sleep apnea
  • Current or recent (regular use within the past 6 months) use of tobacco or nicotine products (e.g., cigarettes, vaping)
  • Per the POWERbreathe® company:
  • Asthma patients who have a very low symptom perception and suffer from frequent, severe exacerbations or with an abnormally low perception of dyspnoea.
  • Patients with marked elevated left ventricular end-diastolic volume and pressure.
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant (self-reported and urine pregnancy test conducted), lactating (self-reported), or post-menopausal (self-reported) females
  • Prisoners

Who the study is looking for

  • Body mass index values of ≤40 kg/m\^2

Age in the registry: 18 years to 45 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Florida State University
Coordinator of this site? Confirm its status
TallahasseeUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.